Platform Technology Partners Cuts Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Platform Technology Partners lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 28.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,654 shares of the company’s stock after selling 1,482 shares during the quarter. Platform Technology Partners’ holdings in GE HealthCare Technologies were worth $286,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Sanctuary Advisors LLC purchased a new stake in shares of GE HealthCare Technologies during the second quarter valued at approximately $1,382,000. Park Avenue Securities LLC raised its holdings in GE HealthCare Technologies by 38.8% during the 3rd quarter. Park Avenue Securities LLC now owns 4,058 shares of the company’s stock valued at $381,000 after buying an additional 1,135 shares during the last quarter. Daymark Wealth Partners LLC boosted its position in GE HealthCare Technologies by 31.0% during the 3rd quarter. Daymark Wealth Partners LLC now owns 5,936 shares of the company’s stock valued at $557,000 after buying an additional 1,403 shares during the period. CWM LLC grew its holdings in GE HealthCare Technologies by 5.0% in the 3rd quarter. CWM LLC now owns 11,186 shares of the company’s stock worth $1,050,000 after acquiring an additional 531 shares during the last quarter. Finally, Wedmont Private Capital increased its position in shares of GE HealthCare Technologies by 16.2% in the third quarter. Wedmont Private Capital now owns 5,584 shares of the company’s stock valued at $503,000 after acquiring an additional 777 shares during the period. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Price Performance

GEHC opened at $87.64 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.55. The company has a market cap of $40.04 billion, a price-to-earnings ratio of 24.08, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a fifty day simple moving average of $83.34 and a two-hundred day simple moving average of $85.21.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.